Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sergey Brezgin

Showing results (1-10 of 36) with videos related to

Pageof 4
Sort By:
International Journal of Molecular Sciences|December 6, 2019
Dead Cas Systems: Types, Principles, and ApplicationsSergey Brezgin, Anastasiya Kostyusheva, Dmitry Kostyushev, et al.
Emerging Microbes & Infections|November 12, 2021
Host-cell interactions in HBV infection and pathogenesis: the emerging role of m6A modificationAnastasiya Kostyusheva, Sergey Brezgin, Dieter Glebe, et al.
Nucleic Acid Therapeutics|November 19, 2021
CRISPR/Cas and Hepatitis B Therapy: Technological Advances and Practical BarriersDmitry Kostyushev, Anastasiya Kostyusheva, Natalia Ponomareva, et al.
Genes|October 11, 2018
Clinical Implications of Hepatitis B Virus RNA and Covalently Closed Circular DNA in Monitoring Patients with Chronic Hepatitis B Today with a Gaze into the Future: The Field Is Unprepared for a Sterilizing CureAnastasiya Kostyusheva, Dmitry Kostyushev, Sergey Brezgin, et al.
Cellular and Molecular Life Sciences : CMLS|January 24, 2019
Orthologous CRISPR/Cas9 systems for specific and efficient degradation of covalently closed circular DNA of hepatitis B virusDmitry Kostyushev, Sergey Brezgin, Anastasiya Kostyusheva, et al.
Colloids and Surfaces. B, Biointerfaces|July 6, 2026
Safeguarding nanovesicles and their payload: A framework for stable storageArtyom Kachanov, Sergey Brezgin, Anastasiya Kostyusheva, et al.
International Journal of Molecular Sciences|October 8, 2020
Gene Editing by Extracellular VesiclesDmitry Kostyushev, Anastasiya Kostyusheva, Sergey Brezgin, et al.
Scientific Reports|February 14, 2019
Suppressing the NHEJ pathway by DNA-PKcs inhibitor NU7026 prevents degradation of HBV cccDNA cleaved by CRISPR/Cas9Dmitry Kostyushev, Anastasiya Kostyusheva, Sergey Brezgin, et al.
Methods (San Diego, Calif.)|April 11, 2021
CRISPR-Cas systems for diagnosing infectious diseasesAnastasiya Kostyusheva, Sergey Brezgin, Yurii Babin, et al.
Molecules (Basel, Switzerland)|October 29, 2025
m<sup>6</sup>A RNA Modification: Technologies Behind Future Anti-Cancer TherapyKristina Shpiliukova, Artyom Kachanov, Sergey Brezgin, et al.
Pageof 4

Showing results (1-10 of 36) with videos related to

Sort By:
Pageof 4
International Journal of Molecular Sciences|December 6, 2019
Dead Cas Systems: Types, Principles, and ApplicationsSergey Brezgin, Anastasiya Kostyusheva, Dmitry Kostyushev, et al.
Emerging Microbes & Infections|November 12, 2021
Host-cell interactions in HBV infection and pathogenesis: the emerging role of m6A modificationAnastasiya Kostyusheva, Sergey Brezgin, Dieter Glebe, et al.
Nucleic Acid Therapeutics|November 19, 2021
CRISPR/Cas and Hepatitis B Therapy: Technological Advances and Practical BarriersDmitry Kostyushev, Anastasiya Kostyusheva, Natalia Ponomareva, et al.
Genes|October 11, 2018
Clinical Implications of Hepatitis B Virus RNA and Covalently Closed Circular DNA in Monitoring Patients with Chronic Hepatitis B Today with a Gaze into the Future: The Field Is Unprepared for a Sterilizing CureAnastasiya Kostyusheva, Dmitry Kostyushev, Sergey Brezgin, et al.
Cellular and Molecular Life Sciences : CMLS|January 24, 2019
Orthologous CRISPR/Cas9 systems for specific and efficient degradation of covalently closed circular DNA of hepatitis B virusDmitry Kostyushev, Sergey Brezgin, Anastasiya Kostyusheva, et al.
Colloids and Surfaces. B, Biointerfaces|July 6, 2026
Safeguarding nanovesicles and their payload: A framework for stable storageArtyom Kachanov, Sergey Brezgin, Anastasiya Kostyusheva, et al.
International Journal of Molecular Sciences|October 8, 2020
Gene Editing by Extracellular VesiclesDmitry Kostyushev, Anastasiya Kostyusheva, Sergey Brezgin, et al.
Scientific Reports|February 14, 2019
Suppressing the NHEJ pathway by DNA-PKcs inhibitor NU7026 prevents degradation of HBV cccDNA cleaved by CRISPR/Cas9Dmitry Kostyushev, Anastasiya Kostyusheva, Sergey Brezgin, et al.
Methods (San Diego, Calif.)|April 11, 2021
CRISPR-Cas systems for diagnosing infectious diseasesAnastasiya Kostyusheva, Sergey Brezgin, Yurii Babin, et al.
Molecules (Basel, Switzerland)|October 29, 2025
m<sup>6</sup>A RNA Modification: Technologies Behind Future Anti-Cancer TherapyKristina Shpiliukova, Artyom Kachanov, Sergey Brezgin, et al.
Pageof 4